Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
Chemotherapy-Induced Nausea and Vomiting (CINV) is one of the devastating side effects for patients undergoing cancer treatment. It is caused when various types of poisonous substances such as chemotherapeutic agents enter in the human body and alert the digestive system during chemotherapy. Besides chemotherapy, there are various types of factors that puts a patient high risk for CINV including female sex, history of alcohol use, CINV & motion sickness and anxiety or depression.
SCOPE OF THE REPORT:
The global CINV & PONV market is expected to grow with increasing cancer incidence, growing female population, increasing pharmaceutical R&D spending, growing healthcare expenditure and accelerating economic growth. Key trends and developments of this market includes progressing drugs under pipeline, high demand for combination therapy and increasing preference for pressure point therapy. However, there are some factors which can hinder growth of the market including entry of generics, stringent regulations and treatment cost.
The global Chemotherapy-Induced Nausea and Vomiting (CINV) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Chemotherapy-Induced Nausea and Vomiting (CINV).
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Chemotherapy-Induced Nausea and Vomiting (CINV) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Chemotherapy-Induced Nausea and Vomiting (CINV) market by product type and applications/end industries.
Market Segment by Companies, this report covers
SCOPE OF THE REPORT:
The global CINV & PONV market is expected to grow with increasing cancer incidence, growing female population, increasing pharmaceutical R&D spending, growing healthcare expenditure and accelerating economic growth. Key trends and developments of this market includes progressing drugs under pipeline, high demand for combination therapy and increasing preference for pressure point therapy. However, there are some factors which can hinder growth of the market including entry of generics, stringent regulations and treatment cost.
The global Chemotherapy-Induced Nausea and Vomiting (CINV) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Chemotherapy-Induced Nausea and Vomiting (CINV).
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Chemotherapy-Induced Nausea and Vomiting (CINV) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Chemotherapy-Induced Nausea and Vomiting (CINV) market by product type and applications/end industries.
Market Segment by Companies, this report covers
- Merck
- Eisai
- ProStrakan
- Helsinn Holding
- Mundipharma
- Qilu Pharma
- Teva
- Novartis
- Heron Therapeutics
- Roche
- Mylan
- Tesaro
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
- CINV
- PONV
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Centers
1 CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) MARKET OVERVIEW
1.1 Product Overview and Scope of Chemotherapy-Induced Nausea and Vomiting (CINV)
1.2 Classification of Chemotherapy-Induced Nausea and Vomiting (CINV) by Types
1.2.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Comparison by Types (2017-2023)
1.2.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Types in 2017
1.2.3 CINV
1.2.4 PONV
1.3 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market by Application
1.3.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.4 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market by Regions
1.4.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Chemotherapy-Induced Nausea and Vomiting (CINV) Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Chemotherapy-Induced Nausea and Vomiting (CINV) Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Chemotherapy-Induced Nausea and Vomiting (CINV) Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Chemotherapy-Induced Nausea and Vomiting (CINV) Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Chemotherapy-Induced Nausea and Vomiting (CINV) Status and Prospect (2013-2023)
1.5 Global Market Size of Chemotherapy-Induced Nausea and Vomiting (CINV) (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Business Overview
2.1.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eisai
2.2.1 Business Overview
2.2.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
2.3 ProStrakan
2.3.1 Business Overview
2.3.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
2.4 Helsinn Holding
2.4.1 Business Overview
2.4.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
2.5 Mundipharma
2.5.1 Business Overview
2.5.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
2.6 Qilu Pharma
2.6.1 Business Overview
2.6.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
2.7 Teva
2.7.1 Business Overview
2.7.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
2.8 Novartis
2.8.1 Business Overview
2.8.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
2.9 Heron Therapeutics
2.9.1 Business Overview
2.9.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
2.10 Roche
2.10.1 Business Overview
2.10.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
2.11 Mylan
2.11.1 Business Overview
2.11.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
2.12 Tesaro
2.12.1 Business Overview
2.12.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) MARKET COMPETITION, BY PLAYERS
3.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Chemotherapy-Induced Nausea and Vomiting (CINV) Players Market Share
3.2.2 Top 10 Chemotherapy-Induced Nausea and Vomiting (CINV) Players Market Share
3.3 Market Competition Trend
4 GLOBAL CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) MARKET SIZE BY REGIONS
4.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Market Share by Regions
4.2 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
4.3 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
4.5 South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) REVENUE BY COUNTRIES
5.1 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Countries (2013-2018)
5.2 USA Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
5.3 Canada Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
5.4 Mexico Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
6 EUROPE CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) REVENUE BY COUNTRIES
6.1 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Countries (2013-2018)
6.2 Germany Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
6.3 UK Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
6.4 France Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
6.5 Russia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
6.6 Italy Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) REVENUE BY COUNTRIES
7.1 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Countries (2013-2018)
7.2 China Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
7.3 Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
7.4 Korea Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
7.5 India Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) REVENUE BY COUNTRIES
8.1 South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Countries (2013-2018)
8.2 Brazil Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
8.3 Argentina Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
8.4 Colombia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) BY COUNTRIES
9.1 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Countries (2013-2018)
9.2 Saudi Arabia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
9.3 UAE Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
9.4 Egypt Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
9.5 Nigeria Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
9.6 South Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
10 GLOBAL CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) MARKET SEGMENT BY TYPE
10.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Market Share by Type (2013-2018)
10.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Forecast by Type (2018-2023)
10.3 CINV Revenue Growth Rate (2013-2023)
10.4 PONV Revenue Growth Rate (2013-2023)
11 GLOBAL CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) MARKET SEGMENT BY APPLICATION
11.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Application (2013-2018)
11.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Ambulatory Surgical Centers Revenue Growth (2013-2018)
11.5 Diagnostic Centers Revenue Growth (2013-2018)
12 GLOBAL CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) MARKET SIZE FORECAST (2018-2023)
12.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Forecast (2018-2023)
12.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Forecast by Regions (2018-2023)
12.3 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2018-2023)
12.4 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2018-2023)
12.6 South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
1.1 Product Overview and Scope of Chemotherapy-Induced Nausea and Vomiting (CINV)
1.2 Classification of Chemotherapy-Induced Nausea and Vomiting (CINV) by Types
1.2.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Comparison by Types (2017-2023)
1.2.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Types in 2017
1.2.3 CINV
1.2.4 PONV
1.3 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market by Application
1.3.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.4 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market by Regions
1.4.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Chemotherapy-Induced Nausea and Vomiting (CINV) Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Chemotherapy-Induced Nausea and Vomiting (CINV) Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Chemotherapy-Induced Nausea and Vomiting (CINV) Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Chemotherapy-Induced Nausea and Vomiting (CINV) Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Chemotherapy-Induced Nausea and Vomiting (CINV) Status and Prospect (2013-2023)
1.5 Global Market Size of Chemotherapy-Induced Nausea and Vomiting (CINV) (2013-2023)
2 MANUFACTURERS PROFILES
2.1 Merck
2.1.1 Business Overview
2.1.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
2.2 Eisai
2.2.1 Business Overview
2.2.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
2.3 ProStrakan
2.3.1 Business Overview
2.3.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
2.4 Helsinn Holding
2.4.1 Business Overview
2.4.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
2.5 Mundipharma
2.5.1 Business Overview
2.5.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
2.6 Qilu Pharma
2.6.1 Business Overview
2.6.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
2.7 Teva
2.7.1 Business Overview
2.7.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
2.8 Novartis
2.8.1 Business Overview
2.8.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
2.9 Heron Therapeutics
2.9.1 Business Overview
2.9.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
2.10 Roche
2.10.1 Business Overview
2.10.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
2.11 Mylan
2.11.1 Business Overview
2.11.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
2.12 Tesaro
2.12.1 Business Overview
2.12.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
3 GLOBAL CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) MARKET COMPETITION, BY PLAYERS
3.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Chemotherapy-Induced Nausea and Vomiting (CINV) Players Market Share
3.2.2 Top 10 Chemotherapy-Induced Nausea and Vomiting (CINV) Players Market Share
3.3 Market Competition Trend
4 GLOBAL CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) MARKET SIZE BY REGIONS
4.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Market Share by Regions
4.2 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
4.3 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
4.5 South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
5 NORTH AMERICA CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) REVENUE BY COUNTRIES
5.1 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Countries (2013-2018)
5.2 USA Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
5.3 Canada Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
5.4 Mexico Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
6 EUROPE CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) REVENUE BY COUNTRIES
6.1 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Countries (2013-2018)
6.2 Germany Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
6.3 UK Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
6.4 France Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
6.5 Russia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
6.6 Italy Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
7 ASIA-PACIFIC CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) REVENUE BY COUNTRIES
7.1 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Countries (2013-2018)
7.2 China Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
7.3 Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
7.4 Korea Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
7.5 India Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
8 SOUTH AMERICA CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) REVENUE BY COUNTRIES
8.1 South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Countries (2013-2018)
8.2 Brazil Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
8.3 Argentina Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
8.4 Colombia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
9 MIDDLE EAST AND AFRICA REVENUE CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) BY COUNTRIES
9.1 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Countries (2013-2018)
9.2 Saudi Arabia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
9.3 UAE Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
9.4 Egypt Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
9.5 Nigeria Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
9.6 South Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
10 GLOBAL CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) MARKET SEGMENT BY TYPE
10.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Market Share by Type (2013-2018)
10.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Forecast by Type (2018-2023)
10.3 CINV Revenue Growth Rate (2013-2023)
10.4 PONV Revenue Growth Rate (2013-2023)
11 GLOBAL CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) MARKET SEGMENT BY APPLICATION
11.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Application (2013-2018)
11.2 Chemotherapy-Induced Nausea and Vomiting (CINV) Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Ambulatory Surgical Centers Revenue Growth (2013-2018)
11.5 Diagnostic Centers Revenue Growth (2013-2018)
12 GLOBAL CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING (CINV) MARKET SIZE FORECAST (2018-2023)
12.1 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Size Forecast (2018-2023)
12.2 Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Forecast by Regions (2018-2023)
12.3 North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2018-2023)
12.4 Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2018-2023)
12.6 South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2018-2023)
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Data Source
LIST OF TABLES AND FIGURES
Figure Chemotherapy-Induced Nausea and Vomiting (CINV) Picture
Table Product Specifications of Chemotherapy-Induced Nausea and Vomiting (CINV)
Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) and Revenue (Million USD) Market Split by Product Type
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Types in 2017
Figure CINV Picture
Figure PONV Picture
Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) by Application (2013-2023)
Figure Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Ambulatory Surgical Centers Picture
Figure Diagnostic Centers Picture
Table Global Market Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) and Growth Rate (2013-2023)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
Table Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
Table Eisai Basic Information, Manufacturing Base and Competitors
Table Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
Table Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
Table ProStrakan Basic Information, Manufacturing Base and Competitors
Table ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
Table ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
Table Helsinn Holding Basic Information, Manufacturing Base and Competitors
Table Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
Table Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
Table Mundipharma Basic Information, Manufacturing Base and Competitors
Table Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
Table Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
Table Qilu Pharma Basic Information, Manufacturing Base and Competitors
Table Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
Table Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
Table Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
Table Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
Table Heron Therapeutics Basic Information, Manufacturing Base and Competitors
Table Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
Table Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
Table Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
Table Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
Table Tesaro Basic Information, Manufacturing Base and Competitors
Table Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
Table Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) by Players (2013-2018)
Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Players (2013-2018)
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Players in 2016
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Players in 2017
Figure Global Top 5 Players Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share in 2017
Figure Global Top 10 Players Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share in 2017
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) by Regions (2013-2018)
Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Regions (2013-2018)
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Regions (2013-2018)
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Regions in 2017
Figure North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Table North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Countries (2013-2018)
Table North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries (2013-2018)
Figure North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries (2013-2018)
Figure North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries in 2017
Figure USA Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Canada Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Mexico Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Table Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) by Countries (2013-2018)
Figure Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries (2013-2018)
Figure Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries in 2017
Figure Germany Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure UK Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure France Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Russia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Italy Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries in 2017
Figure China Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Korea Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure India Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Table South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Countries (2013-2018)
Table South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries (2013-2018)
Figure South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries (2013-2018)
Figure South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries in 2017
Figure Brazil Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Argentina Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Colombia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries in 2017
Figure Saudi Arabia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure UAE Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Egypt Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Nigeria Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure South Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) by Type (2013-2018)
Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Type (2013-2018)
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Type (2013-2018)
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Type in 2017
Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Forecast by Type (2018-2023)
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share Forecast by Type (2018-2023)
Figure Global CINV Revenue Growth Rate (2013-2018)
Figure Global PONV Revenue Growth Rate (2013-2018)
Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Application (2013-2018)
Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Application (2013-2018)
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Application (2013-2018)
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Application in 2017
Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Forecast by Application (2018-2023)
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Ambulatory Surgical Centers Revenue Growth Rate (2013-2018)
Figure Global Diagnostic Centers Revenue Growth Rate (2013-2018)
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2018-2023)
Figure Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2018-2023)
Figure South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2018-2023)
Figure Chemotherapy-Induced Nausea and Vomiting (CINV) Picture
Table Product Specifications of Chemotherapy-Induced Nausea and Vomiting (CINV)
Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) and Revenue (Million USD) Market Split by Product Type
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Types in 2017
Figure CINV Picture
Figure PONV Picture
Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) by Application (2013-2023)
Figure Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Applications in 2017
Figure Hospitals Picture
Figure Ambulatory Surgical Centers Picture
Figure Diagnostic Centers Picture
Table Global Market Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) and Growth Rate (2013-2023)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
Table Merck Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
Table Eisai Basic Information, Manufacturing Base and Competitors
Table Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
Table Eisai Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
Table ProStrakan Basic Information, Manufacturing Base and Competitors
Table ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
Table ProStrakan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
Table Helsinn Holding Basic Information, Manufacturing Base and Competitors
Table Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
Table Helsinn Holding Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
Table Mundipharma Basic Information, Manufacturing Base and Competitors
Table Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
Table Mundipharma Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
Table Qilu Pharma Basic Information, Manufacturing Base and Competitors
Table Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
Table Qilu Pharma Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
Table Teva Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
Table Novartis Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
Table Heron Therapeutics Basic Information, Manufacturing Base and Competitors
Table Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
Table Heron Therapeutics Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
Table Roche Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
Table Mylan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
Table Tesaro Basic Information, Manufacturing Base and Competitors
Table Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Type and Applications
Table Tesaro Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue, Gross Margin and Market Share (2016-2017)
Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) by Players (2013-2018)
Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Players (2013-2018)
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Players in 2016
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Players in 2017
Figure Global Top 5 Players Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share in 2017
Figure Global Top 10 Players Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share in 2017
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) by Regions (2013-2018)
Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Regions (2013-2018)
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Regions (2013-2018)
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Regions in 2017
Figure North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Table North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Countries (2013-2018)
Table North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries (2013-2018)
Figure North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries (2013-2018)
Figure North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries in 2017
Figure USA Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Canada Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Mexico Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Table Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) by Countries (2013-2018)
Figure Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries (2013-2018)
Figure Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries in 2017
Figure Germany Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure UK Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure France Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Russia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Italy Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries in 2017
Figure China Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Japan Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Korea Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure India Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Table South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Countries (2013-2018)
Table South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries (2013-2018)
Figure South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries (2013-2018)
Figure South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries in 2017
Figure Brazil Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Argentina Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Colombia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share by Countries in 2017
Figure Saudi Arabia Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure UAE Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Egypt Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure Nigeria Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Figure South Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue and Growth Rate (2013-2018)
Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) by Type (2013-2018)
Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Type (2013-2018)
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Type (2013-2018)
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Type in 2017
Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Forecast by Type (2018-2023)
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share Forecast by Type (2018-2023)
Figure Global CINV Revenue Growth Rate (2013-2018)
Figure Global PONV Revenue Growth Rate (2013-2018)
Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue by Application (2013-2018)
Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Application (2013-2018)
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Application (2013-2018)
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Share by Application in 2017
Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Forecast by Application (2018-2023)
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Market Share Forecast by Application (2018-2023)
Figure Global Hospitals Revenue Growth Rate (2013-2018)
Figure Global Ambulatory Surgical Centers Revenue Growth Rate (2013-2018)
Figure Global Diagnostic Centers Revenue Growth Rate (2013-2018)
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2018-2023)
Figure Europe Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2018-2023)
Figure South America Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Chemotherapy-Induced Nausea and Vomiting (CINV) Revenue Market Forecast (2018-2023)
